论文部分内容阅读
目的观察肝动脉栓塞化疗术(TACE)联合CT引导下射频消融(RFA)治疗肝癌的效果。方法原发性肝癌患者112例,随机分为观察组与对照组各56例,对照组仅予TACE治疗,观察组予TACE联合CT引导下RFA治疗。观察2组临床效果、复发率及1、2及3年内生存率。结果观察组总有效率94.64%,明显高于对照组的80.36%(P<0.05)。治疗后6个月随访,观察组肿瘤复发2例(3.57%),低于对照组的复发9例(16.07%)(P<0.05)。观察组治疗后1、2及3年生存率均高于对照组(P<0.05)。结论 TACE联合CT引导下RFA治疗肝癌的治疗效果显著,安全性高。值得临床推广应用。
Objective To observe the effect of transcatheter arterial chemoembolization (TACE) and CT-guided radiofrequency ablation (RFA) in the treatment of liver cancer. Methods A total of 112 patients with primary hepatocellular carcinoma (HCC) were randomly divided into observation group (56 cases) and control group (56 cases). The control group received only TACE treatment. The observation group received TACE combined with CT-guided RFA treatment. The clinical effects, recurrence rate and survival rates in 1, 2 and 3 years were observed in two groups. Results The total effective rate in observation group was 94.64%, which was significantly higher than that in control group (80.36%, P <0.05). Six months after the treatment, 2 cases (3.57%) of tumor recurrence in the observation group were observed, which was lower than that in the control group (9 cases, 16.07%) (P <0.05). The 1, 2 and 3-year survival rates in the observation group were significantly higher than those in the control group (P <0.05). Conclusion TACE combined with CT-guided RFA for the treatment of liver cancer has a significant effect and high safety. Worthy of clinical application.